Agilent to Participate in Jefferies Global Healthcare Conference
Get Alerts A Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.8%
EPS Growth %: +8.8%
Join SI Premium – FREE
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT.
Those interested in listening to the live or recorded session can access it from the Agilent Investor Relations website. The recording will be available for 90 days.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240517008367/en/
INVESTOR CONTACT:
Parmeet Ahuja
+1 408 345 8948
[email protected]
MEDIA CONTACT:
Sarah Litton
+1 408 361 0405
[email protected]
Source: Agilent Technologies Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Photos of the Nintendo Experiences at San Diego Comic-Con are Available on Business Wire’s Website
- Bitcoin Price Prediction: Macro Volatility Pushes Crypto Capital Toward AlphaPepe’s Product-Backed Presale
- Building the Next Chapter of EV Infrastructure
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share